Cargando…
Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
Autores principales: | Mohanan, E., Panetta, J. C., Lakshmi, K. M., Edison, E. S., Korula, A., Fouzia, N. A., Abraham, A., Viswabandya, A., Mathews, V., George, B., Srivastava, A., Balasubramanian, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327191/ https://www.ncbi.nlm.nih.gov/pubmed/30135463 http://dx.doi.org/10.1038/s41409-018-0276-4 |
Ejemplares similares
-
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E, et al.
Publicado: (2017) -
Fludarabine-Based Low-Intensity Conditioning for Fanconi Anemia is Associated with Good Outcomes in Aplastic Anemia but not in MDS - a Single-Center Experience
por: Chattopadhyay, Sohini, et al.
Publicado: (2023) -
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
por: Przychodzen, Bartlomiej, et al.
Publicado: (2017) -
Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin
por: Yang, Dan, et al.
Publicado: (2019) -
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi Anemia
por: Fumani, Hosein Kamranzadeh, et al.
Publicado: (2016)